Renaissance Technologies - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 90 filers reported holding HUMACYTE INC in Q4 2023. The put-call ratio across all filers is 1.91 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of HUMACYTE INC
ValueSharesWeighting
Q2 2024$2,881,440
+1226044.7%
600,300
+693.0%
0.01%
Q1 2024$235
-13.0%
75,700
-20.4%
0.00%
Q4 2023$270
-14.3%
95,100
-11.5%
0.00%
-100.0%
Q3 2023$315
+53.7%
107,500
+50.1%
0.00%
Q2 2023$205
+39.5%
71,600
+50.1%
0.00%
Q1 2023$147
+194.0%
47,700
+100.4%
0.00%
Q4 2022$50
-100.0%
23,800
-88.6%
0.00%
-100.0%
Q3 2022$678,000
+1783.3%
208,000
+1773.9%
0.00%
Q2 2022$36,000
-89.2%
11,100
-76.4%
0.00%
Q1 2022$333,000
+211.2%
47,100
+218.2%
0.00%
Q4 2021$107,00014,8000.00%
Other shareholders
HUMACYTE INC shareholders Q4 2023
NameSharesValueWeighting ↓
Endowment Wealth Management, Inc. 100,518$482,4860.35%
Monashee Investment Management LLC 280,000$1,344,0000.17%
United Asset Strategies, Inc. 218,308$1,047,8780.10%
HAMILTON LANE ADVISORS LLC 21,893$105,0860.08%
GSA CAPITAL PARTNERS LLP 224,179$1,0760.08%
David J Yvars Group 22,750$109,2000.07%
ARS Investment Partners, LLC 116,419$558,8110.05%
EntryPoint Capital, LLC 5,180$24,8640.04%
Virtu Financial LLC 103,163$4950.04%
Anson Funds Management LP 50,000$240,0000.03%
View complete list of HUMACYTE INC shareholders